semaglutide nash Inching Closer to a Cure: Daily Achieves Resolution of NASH but Not Fibrosis after 72 Weeks semaglutide nash results Effects of

At 72 weeks, 62.9% of patients in the semaglutide group achieved resolution of steatohepatitis without worsening of fibrosis, compared to 34.3% in the placebo group (estimated difference: 28.%

But some users do report mild side effects, including: Headaches or dizziness (typically at higher doses or when stacking with GH-related peptides) Injection site irritation , redness, or swelling Nausea or GI discomfort when taken orally (more common with low-quality forms) Changes in mood or energy , including restlessness or mild anxiety These symptoms are usually temporary and resolve quickly with dosage adjustment or cycling off

When they do so, they have similar effects as natural GLP-1

Diets fail

NAC treatment alters the transcriptomics in TSPCs To understand how NAC treatment modulated the tenogenic differentiation of TSPCs, TSPCs were treated with or without NAC and their transcriptomics were analyzed